Alpha 2.0
Login Register
» Authors » G C Viberti

G C Viberti

Explore the profile of G C Viberti including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 152
Citations 1953
Followers 0
Related Specialties
Endocrinology
General Medicine
Nephrology
Top 10 Co-Authors
H Keen
R J Jarrett
J C Pickup
J J Bending
M J Wiseman
R W Bilous
J D Walker
S De Cosmo
A Morocutti
S M Thomas
Published In
Diabetologia
Diabet Med
Lancet
Diabetes Care
Br Med J (Clin Res Ed)
Affiliations
Soon will be listed here.
Recent Articles
1.
Determinants of urinary albumin excretion within the normal range in patients with type 2 diabetes: the Randomised Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) study
Ritz E, Viberti G, Ruilope L, Rabelink A, Izzo Jr J, Katayama S, et al.
Diabetologia . 2009 Oct; 53(1):49-57. PMID: 19876613
Aims/hypothesis: In contrast to microalbuminuric type 2 diabetic patients, the factors correlated with urinary albumin excretion are less well known in normoalbuminuric patients. This may be important because even within...
2.
Genetic association analyses of non-synonymous single nucleotide polymorphisms in diabetic nephropathy
Savage D, Patterson C, Deloukas P, Whittaker P, McKnight A, Morrison J, et al.
Diabetologia . 2008 Sep; 51(11):1998-2002. PMID: 18773191
Aims/hypothesis: Diabetic nephropathy, characterised by persistent proteinuria, hypertension and progressive kidney failure, affects a subset of susceptible individuals with diabetes. It is also a leading cause of end-stage renal disease...
3.
Misleading meta-analysis: a need to look beyond the headlines
Chaturvedi N, Bilous R, Hardy R, Remuzzi G, Ruggenenti P, Viberti G
Diabet Med . 2007 May; 24(6):587-91. PMID: 17490423
No abstract available.
4.
Comment on: Boden et al. (2007) Combined use of rosiglitazone and fenofibrate in patients with type 2 diabetes: prevention of fluid retention: Diabetes 56:248-255
Karalliedde J, Viberti G
Diabetes . 2007 May; 56(5):e3. PMID: 17470560
No abstract available.
5.
Metabolic syndrome in obese Caucasian children: prevalence using WHO-derived criteria and association with nontraditional cardiovascular risk factors
Invitti C, Maffeis C, Gilardini L, Pontiggia B, Mazzilli G, Girola A, et al.
Int J Obes (Lond) . 2006 Mar; 30(4):627-33. PMID: 16570092
Objective: Studies on the prevalence of metabolic syndrome (MS) in European obese children using child-based criteria are scanty. Moreover, it is unknown if nontraditional cardiovascular disease (CVD) risk factors are...
6.
Cardiovascular risk in diabetic kidney disease: a model of chronic renal disease
Thomas S, Viberti G
Kidney Int Suppl . 2005 Aug; (98):S18-20. PMID: 16108965
No abstract available.
7.
Revised vs original QUICKI index during diet + rosiglitazone treatment in obese subjects
Brunani A, Caumo A, Graci S, Margarini C, Viberti G, Liuzzi A
Diabetes Metab . 2005 Jan; 30(5):409-10. PMID: 15671907
No abstract available.
8.
-to: Ong KK, Petry CJ, Emmett PM et al.; ALSPAC study team (2004) Insulin sensitivity and secretion in normal children related to size at birth, postnatal growth, and plasma insulin-like growth factor-I levels. Diabetologia 47:1064-1070
Invitti C, Gilardini L, Mazzilli G, Sartorio A, Viberti G
Diabetologia . 2004 Nov; 47(11):2044-5. PMID: 15565365
No abstract available.
9.
Lack of evidence for the 1484insG variant at the 3'-UTR of the protein tyrosine phosphatase 1B (PTP1B) gene as a genetic determinant of diabetic nephropathy development in type 1 diabetic patients
De Cosmo S, Marucci A, Ciociola E, Di Paola R, Pucci L, Penno G, et al.
Nephrol Dial Transplant . 2004 Aug; 19(9):2419-20. PMID: 15299110
No abstract available.
10.
P38 mitogen-activated protein kinase mediates hexosamine-induced TGFbeta1 mRNA expression in human mesangial cells
Burt D, Gruden G, Thomas S, Tutt P, DellAnna C, Viberti G, et al.
Diabetologia . 2003 Apr; 46(4):531-7. PMID: 12679868
Aims/hypothesis: The hexosamine pathway has been implicated in the induction of TGFbeta1 expression and in the pathophysiology of diabetic glomerulopathy. Glucose-induced TGFbeta1 expression is mediated by p38 mitogen-activated-protein-kinase (p38-MAPK) and...